Skip to content
Altius – Lifestyle
Author:
Colossal Biosciences Inc.
Colossal Foundation and Re:wild Expand Flagship Species Reintroduction Fund to Seven New Species Worldwide
August 5, 2026
Colossal Foundation and University of Tasmania Partner to Combat Devil Facial Tumour Disease with Vaccines and Gene Editing
June 30, 2026
Colossal Biosciences and U.S. Fish and Wildlife Service Launch Landmark BioVault Initiative for Every ESA-Listed Species
June 25, 2026
Colossal Biosciences Hatches First Chicks from Its Fully Artificial Egg System
May 19, 2026
Colossal Biosciences Expands De-extinction Portfolio with Iconic Bluebuck
April 30, 2026